Drug Discovery, Translational Neuroscience & Clinical Trial Innovations

Drug discovery in Alzheimer’s is accelerating through high-throughput screening, AI modeling, and human-relevant cellular systems. Translational neuroscience bridges laboratory findings with clinical testing, improving trial design and patient selection. Innovations aim to reduce failure rates, optimize dosing, and bring disease-modifying therapies to patients faster.

    Related Conference of Drug Discovery, Translational Neuroscience & Clinical Trial Innovations

    February 05-06, 2026

    9th Annual Conference on Skin Cancer and Dermatology

    Paris, France
    April 16-17, 2026

    9th World Cosmetic and Dermatology Congress

    Paris, France
    June 15-16, 2026

    COSMETIC DERMATOLOGY 2026

    Paris, France
    June 22-23, 2026

    28th World Dermatology and Aesthetic Congress

    London, UK
    June 25-26, 2026

    27th World Dermatology Congress

    Paris, France
    July 20-21, 2026

    20th International Conference on Alzheimers Disease & Dementia

    Amsterdam, Netherlands
    August 25-26, 2026

    26th European Dermatology Congress

    Paris, France

    Drug Discovery, Translational Neuroscience & Clinical Trial Innovations Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in